| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8764422 | Medicine - Programa de Formación Médica Continuada Acreditado | 2017 | 5 Pages |
Abstract
In recent years, in an attempt at simplification, there has been a paradigm shift in the treatment of dyslipidaemia. LDL cholesterol remains the main therapeutic target; however it is no longer used as an explicit objective and has been changed for an individualised strategy based on absolute CVR stratification. Therefore, there are three stages to the therapeutic approach: establishing the patient's CVR, setting an individual c-LDL objective, and putting together a therapeutic plan.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
S. SantamarÃa Fernández, M. Vázquez Márquez, V. Bonaiuto,